CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,105 enrolled
Drug / intervention
message delivered via virtual technologybehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03867409
NCT03867409N/ACompleted

The United States Healthy Living Study

University of Florida·interventional·Posted Mar 8, 2019·Updated May 13, 2025

In Brief

A clinical study evaluating message delivered via virtual technology for Colo-rectal Cancer. Completed, enrolled 2,105 participants across 1 site.

Detailed Summary

The purpose of this study is to pilot test the efficacy of a patient-centered, tailored message intervention delivered via virtual human technology for increasing colorectal cancer (CRC) screening within guidelines. Although participation is not limited to these groups, the study team is particularly interested in the feasibility of the intervention for reaching racial/ethnic minority and rural patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 8, 2019
Enrollment StartNov 5, 2018
Primary CompletionMar 14, 2019
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 7.3 years ago

Interventions

message delivered via virtual technologybehavioral

The intervention is precision messaging tailored to target audiences through development and evaluation of culturally sensitive, interactive messages about CRC screening delivered using VHT. The study will investigate whether interactive, tailored messages contribute to an overall enhancement of knowledge of CRC and screening options by eliciting positive attitudes and behaviors toward FIT screening.